Central Bank & Trust Co. Trims Stake in Intuitive Surgical, Inc. $ISRG

Central Bank & Trust Co. reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,336 shares of the medical equipment provider’s stock after selling 1,446 shares during the quarter. Intuitive Surgical accounts for about 1.1% of Central Bank & Trust Co.’s investment portfolio, making the stock its 27th largest position. Central Bank & Trust Co.’s holdings in Intuitive Surgical were worth $6,859,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. Tobam increased its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $27,000. TD Capital Management LLC raised its position in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares in the last quarter. 1248 Management LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at $30,000. Finally, Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth $30,000. Institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Truist raised its price target to $650 and maintains a Buy rating — the upgrade gives visible upside and likely underpins analyst-driven buying interest. Read More. Read More.
• Positive Sentiment: RBC publishes a bullish forecast and RBC Capital keeps an Outperform rating — another large broker calling for strong price appreciation, supporting momentum. Read More. Read More.
• Positive Sentiment: Robert W. Baird reaffirmed its Buy rating — adds to the cluster of brokerages staying constructive, which can sustain inflows. Read More.
• Positive Sentiment: ISRG received a mention on CNBC’s “Final Trades” — media highlights can drive short-term retail/intraday interest. Read More.
• Neutral Sentiment: Company reorganized its digital and AI leadership (effective Jan 1) — signals focus on software/AI strategy but execution and timing are uncertain. Read More.
• Neutral Sentiment: ISRG plans to move to direct distribution in Southern Europe in 2026 to capture distributor economics — could lift margins if executed well, but the analyst note flags execution risk. Read More.
• Neutral Sentiment: Analyst consensus remains a “Moderate Buy” across brokerages — broad support, but not unanimous conviction; reinforces the view of steady analyst backing. Read More.
• Negative Sentiment: Valuation questions after a ~27% three‑month share-price climb — coverage is asking whether ISRG is still undervalued, raising the risk of short-term profit-taking given elevated multiples. Read More.

Insider Transactions at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at $496,455.52. The trade was a 83.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 114,007 shares of company stock valued at $63,533,844. Company insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on ISRG shares. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Royal Bank Of Canada boosted their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday. UBS Group set a $600.00 target price on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Finally, Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $611.08.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $572.47 on Friday. The company has a market capitalization of $205.22 billion, a P/E ratio of 75.72, a PEG ratio of 5.16 and a beta of 1.68. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a 50 day moving average price of $541.48 and a two-hundred day moving average price of $506.30.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the business earned $1.84 earnings per share. The business’s revenue was up 22.9% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.